APA
Irigoyen A., Gallego J., Guillén Ponce C., Vera R., Iranzo V., Ales I., Arévalo S., Pisa A., Martín M., Salud A., Falcó E., Sáenz A., Manzano Mozo J. L., Pulido G., Martínez Galán J., Pazo-Cid R., Rivera F., García García T., Serra O., Fernández Parra E. M., Hurtado A., Gómez Reina M. J., López Gomez L. J., Martínez Ortega E., Benavides M. & Aranda E. (20170807). Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. : European journal of cancer (Oxford, England : 1990).
Chicago
Irigoyen Antonio, Gallego Javier, Guillén Ponce Carmen, Vera Ruth, Iranzo Vega, Ales Inmaculada, Arévalo Sara, Pisa Aleydis, Martín Marta, Salud Antonieta, Falcó Esther, Sáenz Alberto, Manzano Mozo José Luis, Pulido Gema, Martínez Galán Joaquina, Pazo-Cid Roberto, Rivera Fernando, García García Teresa, Serra Olbia, Fernández Parra Eva Ma, Hurtado Alicia, Gómez Reina Ma José, López Gomez Luis Jesús, Martínez Ortega Esther, Benavides Manuel and Aranda Enrique. 20170807. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. : European journal of cancer (Oxford, England : 1990).
Harvard
Irigoyen A., Gallego J., Guillén Ponce C., Vera R., Iranzo V., Ales I., Arévalo S., Pisa A., Martín M., Salud A., Falcó E., Sáenz A., Manzano Mozo J. L., Pulido G., Martínez Galán J., Pazo-Cid R., Rivera F., García García T., Serra O., Fernández Parra E. M., Hurtado A., Gómez Reina M. J., López Gomez L. J., Martínez Ortega E., Benavides M. and Aranda E. (20170807). Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. : European journal of cancer (Oxford, England : 1990).
MLA
Irigoyen Antonio, Gallego Javier, Guillén Ponce Carmen, Vera Ruth, Iranzo Vega, Ales Inmaculada, Arévalo Sara, Pisa Aleydis, Martín Marta, Salud Antonieta, Falcó Esther, Sáenz Alberto, Manzano Mozo José Luis, Pulido Gema, Martínez Galán Joaquina, Pazo-Cid Roberto, Rivera Fernando, García García Teresa, Serra Olbia, Fernández Parra Eva Ma, Hurtado Alicia, Gómez Reina Ma José, López Gomez Luis Jesús, Martínez Ortega Esther, Benavides Manuel and Aranda Enrique. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group. : European journal of cancer (Oxford, England : 1990). 20170807.